key: cord-0969103-yahr10u5 authors: Nakauchi, Mina; Takayama, Ikuyo; Takahashi, Hitoshi; Semba, Shohei; Saito, Shinji; Kubo, Hideyuki; Kaida, Atsushi; Oba, Kunihiro; Nagata, Shiho; Odagiri, Takato; Kageyama, Tsutomu title: Development of real‐time fluorescent reverse transcription loop‐mediated isothermal amplification assays for rhinovirus detection date: 2019-02-22 journal: J Med Virol DOI: 10.1002/jmv.25427 sha: 8e9f24ce4a14bc9a0f4300ea62e1557d1bd0e2a5 doc_id: 969103 cord_uid: yahr10u5 Human rhinoviruses (RVs) belong to the genus Enterovirus of the family Picornaviridae, and are classified into RV‐A, ‐B, and ‐C species. Two assays were developed to detect RVs by a real‐time fluorescent reverse transcription loop‐mediated isothermal amplification method: one was designed based on the 5′‐untranslated regions (UTRs) of RV‐A and ‐B, and the other was designed based on the 5′‐UTR of RV‐C. The competence of both assays for the diagnosis of RV infection was tested using isolated viruses and compared with real‐time reverse transcription polymerase chain reaction assays on clinical specimens. Neither assay demonstrated cross‐reactivity with other tested enteroviruses, and they detected 19 out of 21 tested RV‐As and seven out of eight tested RV‐Cs. The specificity of the assays was 100% for the detection of RVs and their sensitivity for RV‐A and RV‐C was 86.3% and 77.3%, respectively, on clinical specimens by the combined use of both assays. Considering that both developed assays were highly specific and detected the majority of recently circulating RVs, they are helpful for the diagnosis of RV infection. Consequently, the results generated by these assays will enhance the surveillance of respiratory illness and the study of the roles of RVs associated with clinical features and disease severity. Total RNA was prepared from the clinical specimens and isolated viruses using a MagMAX 96 Viral Isolation Kit (Thermo Fisher Scientific, Waltham, MA) (using 50 μL of the clinical specimens and isolated viruses and eluted in 50 μL) with KingFisher Flex (Thermo Fisher Scientific) according to the manufacturerʼs instructions. Purified viral RNA from clinical specimens was reverse-transcribed using random hexamer primers (Promega, Madison, WI) and Super-Script III Reverse Transcriptase (Thermo Fisher Scientific) according to the manufacturerʼs instructions. The complementary DNA (3 µL) was amplified in three separate PCRs using RV species A-, B-, and C-specific primer sets (0.5 μM of each, Table 1 To construct an RNA control to quantify RNA copy number by real-time RT-PCR, the 5′-UTR region of RV-A16 was amplified by RT-PCR, and the resulting PCR product containing the T7 promoter was transcribed in vitro. The detailed procedure is described below. The 5′-UTR region was amplified by PCR using Phusion High-Fidelity DNA Polymerase (New Five percent of the LB primers were substituted with QPrimer-5G for RT-LAMP Set 2 as described in Section 2.6. T A B L E 2 The sensitivity of the RT-LAMP assays was tested using serial dilutions of viral RNA from several RV-A species. Table 1 ). The specificity of each RT-LAMP assay was evaluated using other enteroviruses (human coxsackievirus B4 and B5, human enterovirus A71, and enterovirus D68), and no cross-reactivity was detected (data not shown). The sensitivity of each RT-LAMP assay was evaluated using serially diluted RNAs that were purified from several clinical isolates of RV-A, -B, and -C (Tables 2 and 3 ). The assays were carried out independently three times. The majority of tested RVs were detected by either or both of the RT-LAMP assays, but their respective sensitivity for each RV was different (Tables 2 and 3 ). Both RT-LAMP assays barely reacted with RV-A45, A101, B14, and C23 (Tables 2 and 3 ). The RT-LAMP Set 1 assay detected at least 1.0 × 10 2 , 10 3 , and Figure S1 . The RT-LAMP Set 1 assay reacted with some RV-Cs and with the majority of RV-As, while the RT-LAMP Set 2 assay reacted with some RV-As and with the majority of RV-Cs. The RT-LAMP assays were evaluated using RNA purified from 128 clinical specimens. Of them, 98 clinical specimens were positive for RV by real-time PCR and considered to be a single infection case with either RV-A, -B, or -C depending on the sequence of the 5′-UTR region, as described in Section 3.1. When either or both RT-LAMP assays detected the target, the results were taken as "positive." Neither RT-LAMP assay cross-reacted with 15 (Tables 4 and 5 ). The assay results for 73 clinical specimens that were positive for RV-A by real-time RT-PCR and sequencing showed that the sensitivity of the RT-LAMP assays for RV-A was 86.3% (Table 4) . Similarly, the results for 22 clinical specimens that were positive for RV-C by realtime RT-PCR and sequencing showed that the sensitivity of the RT-LAMP assays for RV-C was 77.3% (Table 5) . Neither assay reacted with three clinical specimens that were positive for RV-B by real-time RT-PCR and sequencing (data not shown). In this study, two assays were developed to detect RVs using an RT-LAMP method with primers that were designed based on recently circulating RVs in Japan. Among nucleic acid amplification T A B L E 4 The performance of the RT-LAMP assays compared with a real-time RT-PCR assay on RV-A-positive specimens techniques, real-time fluorescent RT-LAMP can be performed simply by incubating the reaction tube at 63°C and completed within 30 minutes. 22 Other than real-time RT-PCR and RT-LAMP methods, nucleic acid sequence-based amplification (NASBA) to detect RVs, has been reported. [27] [28] [29] [30] Similar to RT-LAMP, NASBA is an isothermal nucleic acid amplification method that can be performed without the need for expensive equipment. However, NASBA takes 2 hours to generate a result, and requires an annealing step at 65°C before an isothermal amplification step at a lower temperature. 31 It has been more than a decade since NASBA assays for RV detection were reported, and it is still not certain whether these assays can detect recently circulating RVs, especially the recently identified RV-Cs. More recently, reverse transcription strand invasion-based amplification (RT-SIBA), which can be performed isothermally to detect RVs, has been reported 32 ; however, this assay takes more than 1 hour to generate results and has only been evaluated with RV-A and -B, but not with RV-C. Similar to NASBA assays, it is uncertain whether RT-SIBA can detect RV-Cs. RV genomes are highly diverse between different species, as well as within the same species; therefore, molecular assays typically target the 5′-UTR of the viral genome, which contains relatively conserved sequences. 7, 33 Our developed RT-LAMP assays also target the 5′-UTR and had no cross-reactivity with other tested enteroviruses and detected 19 out of 21 tested RV-A species and seven out of eight tested RV-C species (Table 2and 3 ). In contrast, the assays failed to detect two RV-A, 1 RV-B, and 1 RV-C species (Tables 2 and 3 Meanwhile, from the assay results showing a detection rate of 90% for the tested RVs with high sensitivity and specificity (Tables 2 and 3) , the assays were considered to be useful as molecular detection tools for RV infections. Our developed RT-LAMP assays have a sensitivity of 86.3% and 77.3% for detecting RV-A and -C, respectively, in clinical specimens when compared with real-time RT-PCR (Tables 4 and 5 type RVs, and it was shown that the majority of circulating RV species were RV-A and -C, and even the prevalence of each RV species differed in each report. [34] [35] [36] Considering these epidemiological studies and the sensitivity of the developed assays in the present study, it is suggested that the assays can detect 70% to 80% of recently circulating RVs. In conclusion, both of the developed RT-LAMP assays can be performed easily and quickly, are highly specific, and can detect the majority of recently circulating RVs. The assays are considered helpful for the diagnosis of RV infections; consequently, the results will help to enhance the surveillance of respiratory illness and to study the roles of RVs associated with clinical features and disease severity. A collaborative report: rhinoviruses-extension of the numbering system from 89 to 100 Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity The major and minor group receptor families contain all but one human rhinovirus serotype Pathogenesis of rhinovirus infection Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections MassTag polymerase-chainreaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York state during Proposals for the classification of human rhinovirus species A, B, and C into genotypically assigned types Human rhinoviruses Viruses and bacteria in the etiology of the common cold Role of viral infections in the development and exacerbation of asthma in children Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation Rhinovirus associated with severe lower respiratory tract infections in children Rhinovirus outbreak in a long term care facility for elderly persons associated with unusually high mortality New molecular detection tools adapted to emerging rhinoviruses and enteroviruses Usefulness of published PCR primers in detecting human rhinovirus infection Loop-mediated isothermal amplification of DNA Accelerated reaction by loopmediated isothermal amplification using loop primers Evaluation of reverse transcription loop-mediated isothermal amplification assays for rapid diagnosis of pandemic influenza A/H1N1 2009 virus Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects Loop-mediated isothermal amplification technology: towards point of care diagnostics Development of Realtime Fluorescent Reverse Transcription Loop-Mediated Isothermal Amplification Assay with Quenching Primer for Influenza Virus and Respiratory Syncytial Virus In:undersubmitting Development of fluorescent reverse transcription loop-mediated isothermal amplification (RT-LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus A one-step, real-time PCR assay for rapid detection of rhinovirus One-step real-time reverse transcription-PCR assays for detecting and subtyping pandemic influenza A/H1N1 2009, seasonal influenza A/H1N1, and seasonal influenza A/H3N2 viruses Associations between codetected respiratory viruses in children with acute respiratory infections Development of a quantitative real-time nucleic acid sequence-based amplification assay with an internal control using molecular beacon probes for selective and sensitive detection of human rhinovirus serotypes Development and application of a new method for amplification and detection of human rhinovirus RNA Improved detection of rhinoviruses by nucleic acid sequence-based amplification after nucleotide sequence determination of the 5′ noncoding regions of additional rhinovirus strains Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season Nucleic acid sequence-based amplification Detection of human rhinoviruses by reverse transcription strand invasion based amplification method (RT-SIBA) Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution Heterotypic infection and spread of Rhinovirus A, B, and C among child care attendees Molecular epidemiology of rhinovirus detections in young children Epidemiologic, clinical, and virologic characteristics of human rhinovirus infection among otherwise healthy children and adults: rhinovirus among adults and children Development of real-time fluorescent reverse transcription loop-mediated isothermal amplification assays for rhinovirus detection We thank Drs Eri Nobusawa, Kazuya Nakamura, and Itsuki Hamamoto, The authors declared that there is no conflict of interests. http://orcid.org/0000-0001-6545-7448